Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons

[1]  C. Siu,et al.  Pseudo-pre-excitation unraveled down to its core. , 2014, Circulation.

[2]  A. Cuervo,et al.  Chaperone-mediated autophagy: roles in disease and aging , 2013, Cell Research.

[3]  Katarina Kågedal,et al.  The lysosome: from waste bag to potential therapeutic target. , 2013, Journal of molecular cell biology.

[4]  M. Jäättelä,et al.  Lysosomal cell death at a glance , 2013, Journal of Cell Science.

[5]  F. J. Livesey,et al.  Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks , 2012, Nature Protocols.

[6]  Ronald A. Li,et al.  Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level. , 2011, Cellular reprogramming.

[7]  Matthew R. G. Taylor,et al.  Natural history of Danon disease , 2011, Genetics in Medicine.

[8]  J. Turkson,et al.  Stat3 controls lysosomal-mediated cell death in vivo , 2011, Nature Cell Biology.

[9]  C. Lau,et al.  ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. , 2010, Cellular reprogramming.

[10]  K. Öllinger,et al.  Regulation of apoptosis-associated lysosomal membrane permeabilization , 2010, Apoptosis.

[11]  R. Ruivo,et al.  Molecular and cellular basis of lysosomal transmembrane protein dysfunction. , 2009, Biochimica et biophysica acta.

[12]  S. Shirasawa,et al.  Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. , 2008, Cancer research.

[13]  P. Lipton,et al.  Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA‐mediated calcium influx, arachidonic acid metabolism, and free radical production , 2008, Journal of neurochemistry.

[14]  P. Saftig,et al.  LAMP-2: A control step for phagosome and autophagosome maturation , 2008, Autophagy.

[15]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[16]  M. Vatta,et al.  Danon disease as a cause of autophagic vacuolar myopathy. , 2007, Congenital Heart Disease.

[17]  R. Jacob,et al.  The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells , 2007, Journal of cellular biochemistry.

[18]  K. Kågedal,et al.  UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. , 2006, The Journal of investigative dermatology.

[19]  C. Angelini,et al.  Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. , 2006, The American journal of pathology.

[20]  J. Towbin,et al.  Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children , 2005, Circulation.

[21]  A. Kaasik,et al.  Up‐regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium , 2005, The European journal of neuroscience.

[22]  K. Kågedal,et al.  Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. , 2002, The American journal of pathology.

[23]  Y. Uchiyama.  Autophagic cell death and its execution by lysosomal cathepsins. , 2001, Archives of histology and cytology.

[24]  G. Jung,et al.  Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. , 2000, European journal of biochemistry.

[25]  Wei Li,et al.  Induction of cell death by the lysosomotropic detergent MSDH , 2000, FEBS letters.

[26]  B. Halliwell.  Antioxidant defence mechanisms: from the beginning to the end (of the beginning). , 1999, Free radical research.

[27]  K. Öllinger,et al.  Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. , 1998, The American journal of pathology.

[28]  S. Orrenius,et al.  Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis , 1997, FEBS letters.

[29]  M. Fukuda,et al.  The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Localization on the peptide backbones. , 1990, The Journal of biological chemistry.

[30]  J. Matteson,et al.  Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences. , 1988, The Journal of biological chemistry.

[31]  S. Dimauro,et al.  Lysosomal glycogen storage disease with normal acid maltase , 1981, Neurology.

[32]  R. Wattiaux,et al.  Tissue fractionation studies. 5. The association of acid phosphatase with a special class of cytoplasmic granules in rat liver. , 1955, The Biochemical journal.

[33]  P. Sham,et al.  Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. , 2013, Human molecular genetics.

[34]  De,et al.  Tissue Fractionation Studies , 2005 .

[35]  M. Fukuda.  The Polylactosaminoglycans of Human Lysosomal Membrane Glycoproteins Lamp- 1 and Lamp-Z , 2001 .

[36]  J. August,et al.  Lysosomal membrane glycoproteins: properties of LAMP-1 and LAMP-2. , 1986, Biochemical Society symposium.